- Reduced price
 
            Order to parcel locker
 
				
				
					easy pay
 
				
				
					 
            Choose Paczkomat Inpost, Orlen Paczka, DHL, DPD or Poczta Polska. Click for more details
Pay with a quick bank transfer, payment card or cash on delivery. Click for more details
If you are a consumer, you can return the goods within 14 days. Click for more details
Comprehensive resource summarizing recent research on von Willebrand disease, showing clinicians how to optimize management of patients with this disorder
The newly revised and updated second edition of Textbook of von Willebrand Disease:: Basic and Clinical Aspects, 2nd edition describes the important and complex role of von Willebrand factor (VWF) in hemostasis and thrombosis, covering not only the current understanding of its molecular biology, but also the association between genetic variants of VWF and different von Willebrand disease (VWD) phenotypes. The text also reviews the important area of the obstetric and gynecological manifestations of VWD, as well as how to manage patients with VWD for surgery.
Many advances in agents are included in this updated edition, as well as the wide topics such as VWF in Angiogenesis, and VWF/ADAMTS13 as risk factors of thrombosis.
Edited by a team of experts in VWD and an international team of contributors, Textbook of von Willebrand Disease covers sample topics such as::
Providing complete and accessible coverage of the subject, Textbook of von Willebrand Disease:: Basic and Clinical Aspects, 2nd edition is a valuable resource for hematologists in practice and in training, along with specialists in thrombosis, hemostasis, and bleeding/clotting disorders.
Data sheet
List of Contributors vii
Foreword xi
Preface xiii
1 Historical perspective on von Willebrand disease 1
 Erik E. Berntorp and Margareta Blombäck
2 Biosynthesis and organization of von Willebrand factor 7
 Sandra L. Haberichter
3 Von Willebrand factor structure and function 23
 Robert R. Montgomery Veronica H. Flood and Sandra L. Haberichter
4 Regulation of von Willebrand factor expression 39
 Elham Ghorbanpour and David Lillicrap
5 Modulation of VWF by ADAMTS13 49
 Yaoxian Xu Anastasis Petri and James T.B. Crawley
6 Assessment of VWF clearance 63
 Orla Rawley Laura L. Swystun and Jamie M. O’Sullivan
7 Classification of VWD 73
 Jessica Garcia Sandra L. Haberichter and Veronica H. Flood
8 The epidemiology of von Willebrand disease 81
 Giancarlo Castaman and Francesco Rodeghiero
9 Clinical aspects of von Willebrand disease: bleeding history 87
 Paula D. James and Alberto Tosetto
10 Laboratory diagnosis of von Willebrand disease: the phenotype 95
 Emmanuel J. Favaloro and Ulrich Budde
11 Molecular diagnosis of von Willebrand disease: the genotype 109
 Pamela Christopherson Robert R. Montgomery and Veronica H. Flood
12 Clinical laboratory and molecular markers of type 1 von Willebrand disease and low vonWillebrand factor 115
 David Lillicrap
13 Clinical and molecular markers of type 1C VWD 123
 Heather Clift Veronica H. Flood and Sandra L. Haberichter
14 Clinical and molecular markers of VWD2A 129
 Reinhard Schneppenheim and Giancarlo Castaman
15 Clinical and molecular markers of VWD2B 137
 Giancarlo Castaman and Augusto B. Federici
16 Clinical and molecular markers of type 2M VWD 143
 Maissaa Janbain Sandra L. Haberichter and Veronica H. Flood
17 Clinical and molecular markers of VWD2N 149
 Jenny Goudemand and Mélanie Daniel
18 Clinical laboratory and molecular markers of type 3 von Willebrand disease 159
 Luciano Baronciani and Augusto B. Federici
19 Pediatric aspects of von Willebrand disease 177
 Robert F. Sidonio Jr and Jorge Di Paola
20 Women with von Willebrand Disease 185
 Rezan Abdul Kadir
21 The use of desmopressin in von Willebrand disease 201
 Giancarlo Castaman and Augusto B. Federici
22 Plasma-derived and recombinant VWF concentrates 215
 Pier Mannuccio Mannucci and Massimo Franchini
23 Pathophysiology epidemiology and management of acquired von Willebrand syndrome 221
 Ulrich Budde and Augusto B. Federici
24 Cardiovascular causes of AVWS 239
 Antoine Rauch and Sophie Susen
25 Von Willebrand factor regulation of angiogenesis and vascular integrity: implications forgastrointestinal angiodysplasia and beyond 247
 Anna M. Randi and Giancarlo Castaman
26 Prophylaxis in von Willebrand disease 257
 Erik E. Berntorp and Augusto B. Federici
27 Risk of thrombosis and antithrombotic treatment in von Willebrand disease patients 265
 Ferdows Atiq and Frank W.G. Leebeek
28 Novel functions for VWF beyond hemostasis 271
 Ferdows Atiq and James S. O’Donnell
Index 281
Reference: 83318
Author: Matthew Smallman-Raynor
A Geographical Analysis from Medieval Quarantine to Global Eradication
Reference: 47042
Author: John Hart
